Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function.
about
Iron chelation and multiple sclerosis1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310Decreased extracellular adenosine levels lead to loss of hypoxia-induced neuroprotection after repeated episodes of exposure to hypoxia.Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor properties.Imaging PEG-like nanoprobes in tumor, transient ischemia, and inflammatory disease modelsHypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke.Chelation of lysosomal iron protects dopaminergic SH-SY5Y neuroblastoma cells from hydrogen peroxide toxicity by precluding autophagy and Akt dephosphorylation.Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke.Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke.Neuronal HIF-1α and HIF-2α deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke.Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors
P2860
Q27001743-861445C0-4A4E-43DF-ABCD-D8C0642DFF49Q34292783-BC564052-E5C8-4CA7-83FE-BA03FF823B8EQ34599971-2C935C29-351C-4F0F-BBFB-13816D5BDECDQ36079321-D9682A02-EFC2-4CFD-AA77-A4F4A04F2C71Q36579398-C849C539-3EA8-4470-95A6-D7A9D1E7FA9DQ36997095-F9AB5C93-69F0-482F-BD55-52F2B6B8B58EQ37735698-C01D79E5-619C-4A4F-B998-CE4D5048CFDEQ38078689-0C6E9F19-C6A0-485F-BA6E-D7B6D57F533EQ39179240-AEC42F60-22F0-47F0-BF32-3F07CFAF4039Q41856276-64940072-4B0C-4F54-BAC6-A333D28AFAB4Q48221800-0E1CFC27-9CBF-4BE4-8EAB-D3692C1ED579Q49022670-04925324-9C18-4B42-9A96-6E5E444B0BF1Q58575600-20C22383-8E4E-4A6E-8EB8-4122414971DE
P2860
Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prophylactic neuroprotection a ...... independent of HIF-1 function.
@ast
Prophylactic neuroprotection a ...... independent of HIF-1 function.
@en
type
label
Prophylactic neuroprotection a ...... independent of HIF-1 function.
@ast
Prophylactic neuroprotection a ...... independent of HIF-1 function.
@en
prefLabel
Prophylactic neuroprotection a ...... independent of HIF-1 function.
@ast
Prophylactic neuroprotection a ...... independent of HIF-1 function.
@en
P2860
P356
P1476
Prophylactic neuroprotection a ...... independent of HIF-1 function.
@en
P2093
David A Rempe
Yanxin Zhao
P2860
P304
P356
10.1038/JCBFM.2010.230
P577
2011-01-19T00:00:00Z